☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

New MeReC Extra

The National Prescribing Centre has published a new issue of MeRec Extra.

This document covers Antidepressants, Cardiovascular Safety of NSAIDs and Smoking Cessation advice for Pharmacists.

The coverage of antidepressants is a thorough examination of the trial of Escitalopram (Cipralex) versus Citalopram (Cipramil) that has already been covered here with the same key message delivered but in greater detail.

The coverage of the Cardiovascular Safety of NSAIDs has also been covered on this site but again the MeReC covers the topic in greater detail and again the take home message is the same.

Action: The MeRec Extra is a valuable source of information for Primary Care Prescribers. If your practice involves prescribing of NSAIDs or Antidepressants this publication will be of interest.

Share 'New MeReC Extra' by emailShare 'New MeReC Extra' on FacebookShare 'New MeReC Extra' on TwitterShare 'New MeReC Extra' on MastodonShare 'New MeReC Extra' on LinkedInShare 'New MeReC Extra' on reddit

atomic-wealth

No Comments to “New MeReC Extra”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.